Hip Tendinitis Market Research Report – Global Forecast till 2023

Hip Tendinitis Market Research Report – Global Forecast till 2023

ID: MRFR/HC/3339-HCRR | | Region: Global | 90 pages | Half-Cooked Research Reports

Hip Tendinitis Market Research Report, By Type (Internal Snapping, External Snapping, Intra-Articular Snapping Hip), Treatment (Diagnosis, Therapy), End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes) - Global Forecast Till 2023 


Market Scenario:


Hip tendonitis refer to a condition in which single or many tendons connects various muscles to the hip bone, get damaged. The hip and pelvis joints supports the body weight in an upright position. The muscles present in this region are more bulky and strong, however, tendons are prone to damage with increasing age and changing lifestyle. During the last decade, the lifestyle of the people across the globe has changed dramatically. Increasing incident of sports injuries, rising geriatric population, increasing patients population suffering from rheumatoid arthritis & diabetes, and adoption of sedentary lifestyle have led to increase the prevalence of hip tendonitis, which significantly drives the market growth. According to the US centers for diseases control, over 10% of kids and teen participating in the sports suffer from minor or major types of injuries. Additionally, increasing government support for research & development of different drugs, changing lifestyle and lack of exercise have fuelled the market growth. However, long approval time for drugs and lack of precise treatment may slow the growth of the market.


The global hip tendinitis market is expected to grow at a CAGR of 4.55% during forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- Global hip tendinitis market share, by region

Hip Tendinitis Market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation


The global hip tendinitis market is segmented on the basis of types, treatment, and end users.


On the basis of types, the market is segmented into internal snapping hip, external snapping hip, and intra-articular snapping hip.


On the basis of treatment, the market is segmented into diagnosis and therapy. The diagnosis is further segmented into physical exam, imaging tests, and others. Imaging test is further segmented into ultrasound, magnetic resonance imaging (MRI) scans, and others. The therapy is segmented into pharmacological, non-pharmacological, shock wave or surgery, medical devices, and others. The pharmacological therapy is further segmented into OTC drugs, corticosteroids injections, platelet-rich plasma (PRP), and others. The medical devices are further segmented into mechanical band, support tape, pre-cut strips, continuous rolls, and others.


On the basis of end users, the market is segmented into hospitals & clinics, medical research centers, academic institutes, and others. 


Regional Analysis


The global hip tendinitis market is dominated by America owing to the presence of huge geriatric population and continuous increasing number of diabetic patients. As per the report published by the population reference bureau, in 2015, the number of Americans ageing over 65 were 46 million, which is expected to reach over 98 million by 2060. Furthermore, increasing number of patients suffering form rheumatoid arthritis, changing lifestyle, and huge healthcare spending have boosted the growth of the market in America. According to the American Diabetes Association, over 30.3 million Americans population were suffering from diabetes in 2015. Additionally, increasing awareness among the people regarding different types of diseases and increasing government support is likely to contribute to the growth of the market during the review period 2017-2023.


Europe accounts for the second largest hip tendinitis market, which is followed by Asia Pacific. According to the Eurostat, in 2016, 19.2% of total European population were over age 65 years. Increasing geriatric population and adoption of sports by the people may drive the market growth. Moreover, availability of funds for research, and government support for research & development are expected to fuel the market growth.


Asia Pacific is the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, and the presence of huge opportunity in the market. On the other hand, the Middle East & Africa holds the least share in the global hip tendinitis market due to presence of poor economy, especially, in African region. The Middle East holds the major share of the Middle East & African market owing to the well-developed healthcare sector and huge healthcare expenditure. 


Research Methodology

Hip Tendinitis Market-


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Key players for global hip tendinitis market


Some of the key players in the global hip tendinitis market are Almatica Pharma, Inc (U.S.), AstraZeneca (U.K.), Bayer AG (Germany), Boehringer Ingelheim Pharmaceuticals, Inc (Germany), Merck & Co., Inc (U.S.), Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc (U.K.), Teva Pharmaceuticals (Taiwan), Lupin Pharmaceuticals, Inc. (India), Geri-Care Pharmaceuticals. (U.S.), and Perrigo Company (U.S),


 





TABLE OF CONTENT    

Chapter 1.    Report Prologue    

Chapter 2.    Market Introduction    


      2.1    Definition    

      2.2    Scope of the Study    

            2.2.1    Research Objective    

            2.2.2    Assumptions    

            2.2.3    Limitations    

Chapter 3.    Research Methodology

      3.1    Introduction

      3.2    Primary Research    

      3.3    Secondary research    

      3.4    Market Size Estimation

Chapter 4.    Market Dynamics

      4.1    Drivers    

      4.2    Restrains

      4.3    Opportunities    

      4.4    Challenges

      4.5    Macroeconomic Indicators

      4.6    Technology Trends & Assessment            

Chapter 5.    Market Factor Analysis

      5.1    Porters Five Forces Analysis

            5.1.1    Bargaining Power of Suppliers    

            5.1.2    Bargaining Power of Buyers

            5.1.3    Threat of New Entrants    

            5.1.4    Threat of Substitutes    

            5.1.5    Intensity of Rivalry    

      5.2    Value Chain Analysis

      5.3    Investment Feasibility Analysis    

      5.4    Pricing Analysis

Chapter 6.    Global Hip Tendinitis Market, by Type

     6.1    Introduction

      6.2    Internal Snapping Hip 

Market Estimates & Forecast, 2017 – 2023

            6.2.1    Vitamin D Deficiency

            6.2.2    Vitamin D-Dependent Hip Tendinitis

      6.3    External Snapping Hip

Market Estimates & Forecast, 2017 – 2023

      6.4    Intra-Articular Snapping Hip

Market Estimates & Forecast, 2017 – 2023

      6.5    Others

Chapter 7.    Global Hip Tendinitis Market, by Treatment

    7.1    Introduction

      7.2    Diagnosis

Market Estimates & Forecast, 2017 – 2023

            7.2.1     Physical Exam

            7.2.2    Imaging Tests

                7.2.2.1    Ultrasound

                7.2.2.2    Magnetic Resonance Imaging (MRI) Scans

                7.2.2.3    Others

            7.2.3    Others

      7.3    Therapy

Market Estimates & Forecast, 2017 – 2023

            7.3.1    Pharmacological

            7.3.2    Non-Pharmacological

            7.3.3    Shock Wave Therapy or Surgery

            7.3.4    Medical Devices

            7.3.5    Others

Chapter 8    Global Hip Tendinitis Market, by End User

      8.1    Introduction

      8.2    Hospitals & Clinics

            8.2.1    Market Estimates & Forecast, 2017 – 2023

      8.3    Medical Research Centers

            8.3.1    Market Estimates & Forecast, 2017 – 2023

      8.4    Academic Institutes

            8.4.1    Market Estimates & Forecast, 2017 – 2023

      8.5    Others

Chapter 9.    Global Hip Tendinitis Market, by Region

      9.1    Introduction

      9.2    America

            9.2.1    North America

                9.2.1.1    US

                9.2.1.1    Canada

            9.2.2    South America

      9.3    Europe

            9.3.1    Western Europe

                9.3.1.1    Germany

                9.3.1.2    France

                9.3.1.3    Italy

                9.3.1.4    Spain

                9.3.1.5    UK

                9.3.1.6    Rest of Western Europe

            9.3.2    Eastern Europe

      9.4    Asia Pacific

            9.4.1    Japan

            9.4.2    China

            9.4.3    India

            9.4.4    Australia

            9.4.5    Republic of Korea

            9.4.6    Rest of Asia Pacific

      9.5    The Middle East & Africa

            9.5.1    United Arab Emirates

            9.5.2     Saudi Arabia

            9.5.3    Oman

            9.5.4    Kuwait

            9.5.5    Qatar

            9.5.6    Rest of the Middle East & Africa

Chapter 10    Company Landscape    

      10.1    Introduction    

      10.2    Market Share Analysis    

      10.3    Key Development & Strategies    

            10.3.1    Key Developments    

Chapter 11    Company Profiles    

      11.1    Almatica Pharma, Inc     

            11.1.1    Company Overview    

            11.1.2    Product Overview    

            11.1.3    Financials    

            11.1.4    SWOT Analysis    

      11.2    AstraZeneca     

            11.2.1    Company Overview    

            11.2.2    Product Overview    

            11.2.3    Financial Overview    

            11.2.4    Key Developments    

            11.2.5    SWOT Analysis    

      11.3    Bayer AG     

            11.3.1    Company Overview    

            11.3.2    Product Overview    

            11.3.3    Financial Overview

            11.3.4    Key Development    

            11.3.5    SWOT Analysis    

      11.4     Boehringer Ingelheim Pharmaceuticals, Inc

            11.4.1    Company Overview    

            11.4.2    Product/Business Segment Overview    

            11.4.3    Financial Overview    

            11.4.4    Key Development    

            11.4.5    SWOT Analysis    

      11.5    Abbott 

            11.5.1    Company Overview    

            11.5.2    Product Overview    

            11.5.3    Financial overview    

            11.5.4    Key Developments    

      11.6    Merck & Co., Inc.    

            11.6.1    Company Overview    

            11.6.2    Product Overview    

            11.6.3    Financial Overview    

            11.6.4    Key Developments    

      11.7    GlaxoSmithKline plc 

            11.7.1    Overview    

            11.7.2    Product Overview    

            11.7.3    Financials    

            11.7.4    Key Developments    

            11.7.5    SWOT Analysis    

    11.8    Others

Chapter 12    MRFR Conclusion    

      12.1    Key Findings    

            12.1.1    From CEO’s View Point    

            12.1.2    Unmet Needs of the Market    

      12.2    Key Companies to Watch    

      12.3    Prediction of Pharmaceutical industry

Chapter 13    Appendix



LIST OF TABLES

Table 1        Hip Tendinitis Industry Synopsis, 2017 – 2023

Table 2        Global Hip Tendinitis Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3        Global Hip Tendinitis Market by Region, 2017 – 2023, (USD Million)

Table 4        Global Hip Tendinitis Market by Types, 2017 – 2023, (USD Million)

Table 5        Global Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 6        Global Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 7        North America Hip Tendinitis Market by Types, 2017 – 2023, (USD Million)

Table 8        North America Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 9        North America Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 10    US Market by Types, 2017 – 2023, (USD Million)

Table 11    US Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 12    US Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 13    Canada Market by Types, 2017 – 2023, (USD Million)

Table 14    Canada Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 15    Canada Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 16    South America Market by Types, 2017 – 2023, (USD Million)

Table 17    South America Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 18    South America Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 19    Europe Market by Types, 2017 – 2023, (USD Million)

Table 20    Europe Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 21    Europe Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 22    Western Europe Market by Types, 2017 – 2023, (USD Million)

Table 23    Western Europe Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 24    Western Europe Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 25    Eastern Europe Market by Types, 2017 – 2023, (USD Million)

Table 26    Eastern Europe Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 27    Eastern Europe Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 28    Asia Pacific Market by Types, 2017 – 2023, (USD Million)

Table 29    Asia Pacific Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 30    Asia Pacific Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

Table 31    Middle East & Africa Market by Types, 2017 – 2023, (USD Million)

Table 32    Middle East & Africa Hip Tendinitis Market by Treatment, 2017 – 2023, (USD Million)

Table 33    Middle East & Africa Hip Tendinitis Market by End Users, 2017 – 2023, (USD Million)

LIST OF FIGURES

Figure 1    Research Process

Figure 2    Segmentation for Global Hip Tendinitis Market

Figure 3    Segmentation Market Dynamics for Global Hip Tendinitis Market

Figure 4    Global Hip Tendinitis market Share, by Type 2016

Figure 5    Global Hip Tendinitis market Share, by Treatment 2016

Figure 6    Global Hip Tendinitis Market Share, by End Users, 2016

Figure 7    Global Hip Tendinitis Market Share, by Region, 2016

Figure 8    North America Hip Tendinitis Market Share, by Country, 2016

Figure 9    Europe Hip Tendinitis Market Share, by Country, 2016

Figure 10    Asia Pacific Hip Tendinitis Market Share, by Country, 2016

Figure 11    Middle East & Africa Hip Tendinitis Market Share, by Country, 2016

Figure 12    Global Hip Tendinitis Market: Company Share Analysis, 2016 (%)

Figure 13    Almatica Pharma, Inc: Key Financials

Figure 14    Almatica Pharma, Inc: Segmental Revenue

Figure 15    Almatica Pharma, Inc: Geographical Revenue

Figure 16    AstraZeneca: Key Financials

Figure 17    AstraZeneca: Segmental Revenue

Figure 18    AstraZeneca: Geographical Revenue 

Figure 19    Bayer AG: Key Financials

Figure 20    Bayer AG: Segmental Revenue

Figure 21    Bayer AG: Geographical Revenue

Figure 22    Abbott: Key Financials

Figure 23    Abbott: Segmental Revenue

Figure 24    Abbott: Geographical Revenue

Figure 25    Merck & Co., Inc.: Key Financials

Figure 26    Merck & Co., Inc.: Segmental Revenue

Figure 27    Merck & Co., Inc.: Geographical Revenue

Figure 28    GlaxoSmithKline plc: Key Financials

Figure 29    GlaxoSmithKline plc: Segmental Revenue

Figure 30    GlaxoSmithKline plc: Geographical Revenue

Figure 31    Boehringer Ingelheim Pharmaceuticals, Inc: Key Financials

Figure 32    Boehringer Ingelheim Pharmaceuticals, Inc: Segmental Revenue

Figure 33    Boehringer Ingelheim Pharmaceuticals, Inc: Geographical Revenue